Anti-CD-19 CAR-T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-CD-19 CAR-T cells, covering 2022-05-26 to 2026-01-22. Get the full timeline:
Most recent: Clinical Trial Update: Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion. [Phase 1]